1296654-72-2

Upstream product

• 3154-51-6 ethyl N-formylglycinate 
• 100-52-7 benzaldehyde 
• 1296654-70-0 ethyl 1-amino-4-methyl-3-phenyl-1H-pyrrole-2-carboxylate 
• 407-25-0 trifluoroacetic anhydride 
• 2999-46-4 Ethyl isocyanoacetate 
• 124901-12-8 ethyl 4-methyl-3-phenyl-1H-pyrrole-2-carboxylate 
• 705-60-2 (2-nitroprop-1-enyl)benzene 

Downstream Products

• 1296654-74-4 ethyl 4-methyl-1-[methyl(trifluoroacetyl)amino]-3-phenyl-1H-pyrrole-2-carboxylate 
• 1296654-84-6 ethyl N-[(4-hydroxy-1,6-dimethyl-2-oxo-5-phenyl-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl)carbonyl]glycinate 
• 1296651-48-3 N-[(4-hydroxy-1,6-dimethyl-2-oxo-5-phenyl-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl)carbonyl]glycine 
• 1296654-76-6 ethyl 4-methyl-1-(methylamino)-3-phenyl-1H-pyrrole-2-carboxylate 
• 1296654-78-8 4-methyl-1-(methylamino)-3-phenyl-1H-pyrrole-2-carboxylic acid 
• 1296654-80-2 1,6-dimethyl-5-phenyl-4H-pyrrolo[1,2-d][1,3,4]oxadiazine-2,4(1H)-dione 
• 1296654-82-4 ethyl 4-hydroxy-1,6-dimethyl-2-oxo-5-phenyl-1,2-dihydropyrrolo[1,2-b]pyridazine-3-carboxylate 

Relevant academic research and scientific papers

NOVEL FUSED PYRIDAZINE DERIVATIVES

The present invention relates to novel fused pyridazine compounds, their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.